New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2013
08:53 EDTWAG, CVS, ESRXCVS says on track to deliver significant cost savings from streamlining efforts
Says expects to hit full run rate of annual savings of $225M-$275M beginning in 2014. Says working with CMS to resolve Medicare Part D sanction; says SilverScript members not affected by this action. In 2013, says expects to retain at least 60% of the scripts gained during the Walgreens (WAG)/Express Scripts (ESRX) impasse. Says will continue to take a "measured approach" to international growth plan. Comments made on the Q4 earnings conference call.
News For CVS;WAG;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 14, 2014
16:39 EDTESRXBerkshire Hathaway gives quarterly update on stakes
Subscribe for More Information
14:53 EDTCVS, ESRXCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
November 13, 2014
14:50 EDTWAGLonestar Capital to shut down by mid-2015, WSJ reports
Subscribe for More Information
14:45 EDTWAGLonestar capital to shut down, DJ reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use